Chemoinformaics analysis of cis-3-Octen-1-ol
| Molecular Weight | 128.215 | nRot | 5 |
| Heavy Atom Molecular Weight | 112.087 | nRig | 1 |
| Exact Molecular Weight | 128.12 | nRing | 0 |
| Solubility: LogS | -2.078 | nHRing | 0 |
| Solubility: LogP | 2.486 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 24.8307 |
| nHD | 1 | BPOL | 16.0513 |
| QED | 0.564 |
| Synth | 2.405 |
| Natural Product Likeliness | 0.41 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.177 |
| MDCK | 0.0000301 |
| BBB | 0.988 |
| PPB | 0.373351 |
| VDSS | 0.992 |
| FU | 0.681731 |
| CYP1A2-inh | 0.905 |
| CYP1A2-sub | 0.702 |
| CYP2c19-inh | 0.412 |
| CYP2c19-sub | 0.829 |
| CYP2c9-inh | 0.088 |
| CYP2c9-sub | 0.233 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.287 |
| CYP3a4-inh | 0.03 |
| CYP3a4-sub | 0.305 |
| CL | 10.835 |
| T12 | 0.604 |
| hERG | 0.036 |
| Ames | 0.01 |
| ROA | 0.042 |
| SkinSen | 0.363 |
| Carcinogencity | 0.091 |
| EI | 0.985 |
| Respiratory | 0.325 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.955514 |